دورية أكاديمية

Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle.

التفاصيل البيبلوغرافية
العنوان: Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle.
المؤلفون: LOBBESTAEL, Evy, Jing ZHAO, RUDENKO, Iakov N., BEYLINA, Aleksandra, Fangye GAO, WETTER, Justin, BEULLENS, Monique, BOLLEN, Mathieu, COOKSON, Mark R., BAEKELANDT, Veerle, NICHOLS, R. Jeremy, TAYMANS, Jean-Marc
المصدر: Biochemical Journal; 11/15/2013, Vol. 456 Issue 1, p119-128, 14p
مصطلحات موضوعية: PHOSPHOPROTEIN phosphatases, PHOSPHORYLATION, DARDARIN, PARKINSON'S disease, PHOSPHATASE inhibitors, DEPHOSPHORYLATION
مستخلص: A cluster of phosphorylation sites in LRRK2 (leucine-rich repeat kinase 2), including Ser910, Ser935, Ser955 and Ser973, is important for PD (Parkinson's disease) pathogenesis as several PD-linked LRRK2 mutants are dephosphorylated at these sites. LRRK2 is also dephosphorylated in cells after pharmacological inhibition of its kinase activity, which is currently proposed as a strategy for disease-modifying PDtherapy. Despite this importance of LRRK2 dephosphorylation in mutant LRRK2 pathological mechanism(s) and in LRRK2's response to inhibition, the mechanism by which thisoccurs is unknown. Therefore we aimed to identify the phosphatase for LRRK2. Using a panel of recombinant phosphatases, we found that PP1 (protein phosphatase 1) efficiently dephosphorylates LRRK2 in vitro. PP1 activity on LRRK2 dephosphorylation was confirmed in cells using PP1 inhibition to reverse LRRK2 dephosphorylation induced by the potent LRRK2 kinase inhibitor LRRK2-IN1 as well as in R1441G mutant LRRK2.We also found that PP1 and LRRK2 can form a complex in cells. Furthermore, we observed that PP1 inhibition modulates LRRK2's cellular phenotype by reducing skein-like LRRK2-positive structures associated withdephosphorylation. In conclusion, the present study reveals PP1 as the physiological LRRK2 phosphatase, responsible for LRRK2 dephosphorylation observed in PD mutant LRRK2 and after LRRK2 kinase inhibition. [ABSTRACT FROM AUTHOR]
Copyright of Biochemical Journal is the property of Portland Press Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:02646021
DOI:10.1042/BJ20121772